A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
about
Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trialA systematic review of randomized, double-blind, placebo-controlled trials examining the clinical efficacy of vitamin D in multiple sclerosisVitamin D supplementation for prevention of mortality in adultsVitamin D for the management of multiple sclerosisThe Use of 1α,25-Dihydroxyvitamin D₃ as an Anticancer AgentVitamin D and Diabetic Complications: True or False Prophet?Update in vitamin D and multiple sclerosisSolar radiation and vitamin D: mitigating environmental factors in autoimmune diseaseVitamin D as an Immunomodulator: Risks with Deficiencies and Benefits of SupplementationIranian consensus on use of vitamin D in patients with multiple sclerosisVitamin D3 for the Treatment of Epilepsy: Basic Mechanisms, Animal Models, and Clinical TrialsVitamin D Actions on CD4(+) T Cells in Autoimmune DiseaseRole of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosisVitamin D and immunityVitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization StudySafety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosisTreatment of an intramammary bacterial infection with 25-hydroxyvitamin D(3)Vitamin D deficiency: implications for acute care in the elderly and in patients with chronic illness.Vitamin D - effects on skeletal and extraskeletal health and the need for supplementation.Vitamin D and inflammatory diseases.Vitamin D in inflammatory diseases.Regulation of Mycobacterium-specific mononuclear cell responses by 25-hydroxyvitamin D3.The VITAH trial VITamin D supplementation and cardiac Autonomic tone in Hemodialysis: a blinded, randomized controlled trialVitamin D for health: a global perspectiveThe association between breast cancer prognostic indicators and serum 25-OH vitamin D levelsVitamin D supplementation: what's known, what to do, and what's needed.Molecular mechanism underlying the impact of vitamin D on disease activity of MS.Shifting imaging targets in multiple sclerosis: from inflammation to neurodegeneration.Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients.Vitamin D in Autoimmunity: Molecular Mechanisms and Therapeutic Potential.The influence of nutritional factors on the prognosis of multiple sclerosis.Vitamin D supplementation for patients with multiple sclerosis treated with interferon-beta: a randomized controlled trial assessing the effect on flu-like symptoms and immunomodulatory properties.The effect of various vitamin D supplementation regimens in breast cancer patients.Does vitamin D affect risk of developing autoimmune disease?: a systematic review.Predominance of Th2 polarization by vitamin D through a STAT6-dependent mechanism.Can vitamin D supplementation prevent bone loss in persons with MS? A placebo-controlled trial.Efficacy of high-dose vitamin D3 supplementation in vitamin D deficient pregnant women with multiple sclerosis: Preliminary findings of a randomized-controlled trial.The initiation and prevention of multiple sclerosis.Effects of vitamin D on retinal nerve fiber layer in vitamin D deficient patients with optic neuritis: Preliminary findings of a randomized, placebo-controlled trial.Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.
P2860
Q21203734-90F3AB47-6C5C-4964-990F-82BF0B54FC42Q22241932-8F96E87D-2994-4030-A4D4-900DF545E2E0Q24201160-8E3ED7DD-DA1D-4B3D-8430-699EA51E8156Q24235702-D02DFE36-1CD9-45C8-82AA-D0C42A069C39Q26749030-95D752EC-5405-45B4-8AD2-2709C0635A38Q26766181-ED0F69BA-AD75-4BDA-9D49-E1A9228D9B8FQ26780466-E06F0229-073A-4530-A56A-FF6480A012ABQ26852741-C1741FA8-92E8-4059-BF06-EA705AA78ED0Q27011804-B3BFA405-E052-46B0-9D21-3CB3438EE81BQ28067025-2476B4FD-1AC0-4EC2-A4F9-B0FC2DF097D3Q28069486-F8F2CB03-D3A5-4A9F-9BD7-EF90E58CB474Q28081150-009D1131-15F7-4403-A440-6E1552998BE7Q28082878-3878B93C-E96D-469E-85AF-4D0353D872D0Q28087758-F0451E81-3184-412D-B0DE-DC3E9E1EADA9Q28608447-027034CF-C70C-485E-B57D-639B8346CF52Q28744264-BDEF84EC-935B-43AC-8846-92D631FB2AE5Q28744341-1F1590BB-16DB-46E3-869E-1BF978EC636BQ30403062-EB52870D-F614-4202-885E-5C25A9345FE0Q30425759-27C9A6D0-A3EE-407F-9ABC-49F6764A0628Q33806322-63F1AAC3-DA28-4F60-B373-26F4A5C57419Q33833563-49336C66-AF01-4646-B74E-E29924D8002DQ33955263-707E6ED5-B606-43E6-BEF7-31A1F4E1A7D4Q34033076-7A24EACF-FF40-49DD-A9AE-404A78F42CBCQ34037261-34771FD5-7176-4957-93D4-BBC0DED50666Q34153722-98E95203-6EB0-4D4E-A683-CE95CE1BA34BQ34264605-9B0E2875-E036-4D3E-8ECB-1EBE828DF4EEQ34268651-AA25EB4D-E900-4CAE-AA7D-B0304D2775BAQ34303664-9A8276EF-1613-4C24-92DA-00B24CFED6C4Q34420069-5575BDA8-7AE6-4C03-877C-9B28B0E6FFF6Q34550631-5F72EAAA-8937-41E3-8431-3F1DA0C2D050Q34643392-C4B82FA0-6761-47A8-BCE2-4743A2D3FC4EQ34773501-C7A32EC3-90C3-4B49-8359-AA811E40FBE3Q34893987-3F476D4D-02AF-4A1F-9170-D4899C2119DFQ34995500-8A39FFC8-D79E-40FA-BADE-5F2C86CDA2DFQ35054693-5ECB5AEF-5FDA-4619-B46E-772CE7CE988CQ35190771-8CC308AB-FFEF-4A98-979F-6CE67CBB64E4Q35666279-C9EC0E85-0875-4353-AAF1-05574B504962Q35741861-CE00031C-1F8D-4E4E-A72A-D0FCD8404CABQ35745304-7FB0314B-7B32-4726-AF5C-4C27AEBC74DDQ35915016-B8FA0E51-15E6-4990-BF48-BB9E977A0F90
P2860
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
@ast
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
@en
type
label
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
@ast
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
@en
prefLabel
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
@ast
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
@en
P2093
P2860
P921
P1433
P1476
A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis
@en
P2093
J M Burton
P O'Connor
P2860
P304
P356
10.1212/WNL.0B013E3181E1CEC2
P407
P577
2010-04-28T00:00:00Z